Detalles de la búsqueda
1.
Long-term real-life experience with rituximab in adult Finnish patients with rheumatoid arthritis refractory or with contraindication to anti-tumor necrosis factor drugs.
J Clin Rheumatol
; 21(1): 24-30, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25539430
2.
Cervical Spine Involvement among Patients with Rheumatoid Arthritis Treated Actively with Treat-to-target Strategy: 10-year Results of the NEO-RACo Study.
J Rheumatol
; 47(8): 1160-1164, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732558
3.
Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience.
Clin Rheumatol
; 26(10): 1693-700, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17332979
4.
Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.
PLoS One
; 12(8): e0183294, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841649
5.
Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
J Rheumatol
; 42(3): 372-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25593230
Resultados
1 -
5
de 5
1
Próxima >
>>